Paul Lammers, MD, MSc

Paul Lammers has more than 30 years of experience in pharmaceuticals and biotechnology. He served as Chief Executive Officer of Triumvira Immunologics, where he raised more than $125 million, and previously as President and Chief Executive Officer of Mirna Therapeutics, raising approximately $160 million before taking the company public on Nasdaq. He was Chief Medical Officer of EMD Serono.